Penn State Hershey Cancer Institute Research
Welcome to Penn State Hershey Cancer Institute
Intellect and discovery characterize growth at the Penn State Hershey Cancer Institute. We continue to emphasize our state-of-the-art interdisciplinary patient care, in which medical, surgical and radiation oncologists jointly determine the best therapeutic course for each patient. We also focus our attention on becoming designated by the National Cancer Institute (NCI). Among other strengths, the Cancer Institute's emphasis on rural, underserved populations is a focus of the CCSG application. Many of these efforts are conducted through the Appalachian Cancer Network by volunteers throughout Pennsylvania who provide education and screening services, as well as behavioral interventions, to reduce cancer risk. Our free-standing facility, which opened June 2009, was designed to reinforce our concept of a community of individuals devoted to providing comprehensive cancer care and finding a cure for cancer.
The Cancer Institute's three scientific programs:
The scientists in the Cancer Control and Population Health and the Mechanisms of Carcinogenesis and Chemoprevention Programs continue collaborative work on two major grants examining the role of tobacco in leading to cancer. In the Experimental Therapeutics Program, our scientists have been awarded several grants from NCI in the area of nanotechnology. These projects, developed with leading researchers at University Park, are aimed at delivering new cancer treatments to individual cancer cells. Through our network of local hospitals throughout central and northeastern Pennsylvania, the Penn State Hershey Cancer Institute brings research to patients in a growing number of communities. Click here for a list of our partners and affiliates.
We continue to expand our research programs. PSHCI now has 143 investigators from 25 academic departments in six colleges located at the Hershey and University Park campuses. Over the past five years, our NCI funding has increased by 16% with a 22% increase in the past 3 years. This is quite impressive given the funding crisis at the NIH. We are making similar strides in the area of clinical trials. In the past year, 18% of our new cancer patients were enrolled on a therapeutic or prevention trial.
The Medical Minute: Simple steps can lead to safe sleep for infants
The number of infants who die each year from sudden infant death syndrome (SIDS) has decreased in recent decades as awareness of safe sleeping habits has increased. Yet each year, babies still die from sudden, unexplained causes.More...
Tickets on sale for Children's Miracle Ball on Nov. 22
The 25th annual Miracle Ball will be held Saturday, Nov. 22, at the Hershey Lodge. The ball begins at 6 p.m. with a reception and silent auction followed by dinner, dancing and entertainment provided by Honey Pump.More...
Tickets available for Neiman Marcus Fashion Show on Dec. 5 at Hotel Hershey
Children's Miracle Network's annual Neiman Marcus Fashion Show returns Dec. 5 to the Hotel Hershey. This elegant runway show and luncheon benefits the children and families of Penn State Hershey Children's Hospital.More...
Comics in illness the topic of the next First Fridays Lecture
The Department of Humanities at Penn State College of Medicine will welcome Katie Green to the November First Fridays Lecture, “SHOW AND TELL: The Power of Comics in Illness,” at noon Nov. 7 in Room C2860.More...